Sii S, Papa N, Yiu TW, Tempo J, et al. Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mL. BJU Int 2024 Nov 28. doi: 10.1111/bju.16597.
PMID: 39607059